Skip to main content

CDSCO Identifies 330 Substandard Drug Samples in September

Published:
First detected:

Insights by Echo AI

The Central Drugs Standard Control Organisation (CDSCO) has identified 330 drug samples as not of standard quality in September 2026. Central Drugs Laboratories identified 42 samples, while State Drugs Testing Laboratories found 288 samples that failed to meet the prescribed quality standards. One drug sample from NCT Delhi was identified as spurious, and the matter is under investigation.

Source coverage

Aggregated

4

records merged

X / Twitter

3

3 unique

Telegram

0

0 unique

RSS

1

1 unique

4 Sources

  1. Press Trust of India avatar

    Press Trust of India

    X / Twitter / @PTI_News

    In September 2026, Central Drugs Laboratories identified 42 drug sampl...

  2. Business Line avatar

    Business Line

    RSS / @thehindubusinessline.com/feeder/default.rss

    CDSCO flags 330 substandard drug samples, one spurious drug in Septemb...

  3. DD News avatar

    DD News

    X / Twitter / @DDNewslive

    #NewsPunch | CDSCO has flagged 330 medicine samples for failing qualit...

Unlock Echo Intelligence

Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.

  • Monitor Telegram, X, and web in one place
  • Add any source, from niche channels to global outlets
  • Build custom feeds around events, regions, entities, or keywords
  • Merge duplicate coverage into one clear, source-transparent story
  • Auto-translate summaries and full articles
  • Search past coverage and use AI-powered editorial tools
View topic feed